CompoAtlas

Shakeology - Greenberry without Lactospore

Testo originale in francese.

Prodotto naturale per la salute autorizzato in Canada

Se questo prodotto fosse venduto in Francia

Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.

Composizione

Ingrediente medicinale e fontePer unità posologica, secondo la fonteMassimo giornaliero, adulto
Camellia sinensis

Fonte : Feuille

42,75 mgNon calcolata
4-alpha-D-glucane glucanohydrolase

Fonte : Aspergillus flavus var. oryzae - En entier

1.282,5 FCC DUNon calcolata
4-alpha-D-glucane glucanohydrolase

Fonte : Aspergillus flavus var. oryzae - En entier

12,83 mgNon calcolata
Acide d-pantothénique

Fonte : D-Pantothénate de calcium

5 mgNon calcolata
Ginkgo biloba

Fonte : Feuille

21,38 mgNon calcolata
Bêta-carotène5.000 UINon calcolata
Bêta-carotène3.000 microgrammesNon calcolata
Linum usitatissimum

Fonte : Graine(s)

1.000 mgNon calcolata
Vitamine B6

Fonte : Chlorhydrate de pyridoxine

2 mgNon calcolata
Euterpe oleracea

Fonte : Fruit

128,25 mgNon calcolata
Malpighia glabra

Fonte : Fruit

256,5 mgNon calcolata
Thiamine

Fonte : Chlorhydrate de thiamine

1,5 mgNon calcolata
Isolat de protéine de lactosérum

Fonte : Bos taurus - Lait

Potenza : 84,6 % Whey protein

10.200 mgNon calcolata
Molybdène

Fonte : Molybdate de sodium (VI) dihydraté

30 microgrammesNon calcolata
Vitamine E

Fonte : Succinate d'acide de d-alpha tocophéryle

10,05 mg ATNon calcolata
Vitamine E

Fonte : Succinate d'acide de d-alpha tocophéryle

15 UINon calcolata
Salvia hispanica

Fonte : Graine(s)

1.100 mgNon calcolata
Manganèse

Fonte : Produit de chélation de manganèse et de protéine végétale hydrolysée (PVH)

2 mgNon calcolata
Amaranthus cruentus

Fonte : Graine(s)

5 mgNon calcolata
Grifola frondosa

Fonte : En entier

85,5 mgNon calcolata
Triacylglycérol lipase

Fonte : Aspergillus niger - En entier

256,5 FCC LUNon calcolata
Triacylglycérol lipase

Fonte : Aspergillus niger - En entier

25,65 mgNon calcolata
Cuivre

Fonte : Sulfate de cuivre pentahydraté

800 microgrammesNon calcolata
bêta-galactosidase

Fonte : Aspergillus flavus var. oryzae - En entier

145,35 mgNon calcolata
bêta-galactosidase

Fonte : Aspergillus flavus var. oryzae - En entier

145,35 FCC ALUNon calcolata

Ingredienti non medicinali

Gomme de xanthane, Saveur de cannelle, Herbe d'orge, Saveur de fraise, Chlorure de sodium, Feuille de Stevia rebaudiana, D-Fructose, Epinard, dérivé sodium-cuivre de la chlorophylline, Pectine, Extrait de fruit de Siraitia Grosvenorii, Acide citrique, Fruit de Lycium, Herbe de blé, Poudre de bleuet

Dosi raccomandate in Canada

PopolazioneEtàQuantità per assunzioneFrequenza
AdultesNon précisée1 Mesures1 jour

Usi autorizzati in Canada

Digestive enzyme. A factor for the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps to form red blood cells. Helps normal growth and development. Helps to maintain proper muscle function. Helps in tissue formation. Source of vitamin A to help maintain eyesight, skin, membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision. Helps in wound healing. An antioxidant for the maintenance of good health. Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps in the function of the thyroid gland. Helps to maintain healthy skin. Helps to maintain immune function. Provides support for healthy glucose metabolism.

Testo originale in francese.

Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.

Avvertenze in Canada

Contre-indications : Do not use if you are pregnant or breastfeeding. Do not use if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment). Do not use if you or your partner are attempting to conceive. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. Do not use if you have a known allergy / hypersensitivity to acerola. If you have milk allergy, do not use this product.

Testo originale in francese.

Effets indésirables connus : Some people may experience mild gastrointestinal bloating, constipation or indigestion. Nausea, vomiting, and diarrhoea have been known to occur, in which case discontinue use (and consult a health care practitioner.) Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use.

Testo originale in francese.

Scheda del prodotto

Titolare
Beachbody, LLC
NPN o DIN-HM
80046060
Stato
Licenza non attiva
Data della licenza
7 novembre 2013
Data di revisione
Non indicata
Forma
Poudre
Via di somministrazione
Orale
Tipo di domanda
Non traditionnelle

Fonte

Scheda ufficiale Health Canada, licenza 80046060

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Testo originale in inglese.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Testo originale in francese.

La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.

Avvertenze ufficiali (Health Canada)

Health Canada pubblica avvertenze su questi ingredienti:

  • Ginkgo biloba
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    GINKGO - GINKGO BILOBA

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Fonti citate da Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Fonti citate da Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Controindicazioni

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Fonti citate da Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Fonti citate da Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Revisione sistematica
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Monografia di Health Canada del 25 luglio 2025

  • Linum usitatissimum
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    FLAXSEED - LINUM USITATISSIMUM

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Si applica ai prodotti: providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    Fonti citate da Health Canada (1)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    Fonti citate da Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Condizione di applicazione: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    Fonti citate da Health Canada (2)
    • Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
    • Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.

    Controindicazioni

    Si applica ai prodotti: providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    Fonti citate da Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    Fonti citate da Health Canada (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
    • Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.

    Reazioni avverse note

    Condizione di applicazione: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    Fonti citate da Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.

    Monografia di Health Canada del 26 luglio 2024

  • Euterpe oleracea
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    ACAI – EUTERPE OLERACEA

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (derMarderosian and Beutler 2008).

    Fonti citate da Health Canada (1)
    • derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.

    Reazioni avverse note

    Stop use if hypersensitivity/allergy occurs (derMarderosian and Beutler 2008).

    Fonti citate da Health Canada (1)
    • derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.

    Monografia di Health Canada del 24 aprile 2026

Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.

La data della prova di questo elenco di ingredienti è sconosciuta.

Il prodotto è cambiato? Fotografi la confezione.

Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.

Invio per analizzare, Maiusc+Invio per una nuova riga